▶ 調査レポート

クローン病診断・治療の世界市場(~2026年)

• 英文タイトル:Global Crohn's Disease Diagnostic and Therapeutic Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。クローン病診断・治療の世界市場(~2026年) / Global Crohn's Disease Diagnostic and Therapeutic Market Size, Status and Forecast 2020-2026 / MRC2-11QY11531資料のイメージです。• レポートコード:MRC2-11QY11531
• 出版社/出版日:QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、96ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:ヘルスケア
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料はクローン病診断・治療のグローバル市場について調査・分析したレポートです。種類別(血液検査、糞便検査、結腸内視鏡検査、軟式S状結腸鏡検査、コンピューター断層撮影、磁気共鳴画像法、カプセル内視鏡検査)市場規模、用途別(クリニック、病院)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別クローン病診断・治療の競争状況、市場シェア
・世界のクローン病診断・治療市場:種類別市場規模 2015年-2020年(血液検査、糞便検査、結腸内視鏡検査、軟式S状結腸鏡検査、コンピューター断層撮影、磁気共鳴画像法、カプセル内視鏡検査)
・世界のクローン病診断・治療市場:種類別市場規模予測 2021年-2026年(血液検査、糞便検査、結腸内視鏡検査、軟式S状結腸鏡検査、コンピューター断層撮影、磁気共鳴画像法、カプセル内視鏡検査)
・世界のクローン病診断・治療市場:用途別市場規模 2015年-2020年(クリニック、病院)
・世界のクローン病診断・治療市場:用途別市場規模予測 2021年-2026年(クリニック、病院)
・北米のクローン病診断・治療市場分析:米国、カナダ
・ヨーロッパのクローン病診断・治療市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのクローン病診断・治療市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のクローン病診断・治療市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのクローン病診断・治療市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):AbbVie、Celgene Corporation、Genetech、Janssen Biotech、Johnson & Johnson、Pfizer、Prometheus Laboratories、Salix Pharmaceuticals、Takeda's Pharmaceutical
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Crohn’s disease is a type of inflammatory bowel disease (IBD) that may affect any part of the gastrointestinal tract from mouth to anus. Signs and symptoms often include abdominal pain, diarrhea, fever, and weight loss.
As the prevalence of the disease increases, it is expected to drive the Crohn’s disease diagnostic and therapeutic market and the increasing demand for prompt diagnosis and multiple symptoms associated with the disease requiring individual therapeutic attention, are increasing the growth of the market.

Market Analysis and Insights: Global Crohn’s Disease Diagnostic and Therapeutic Market
The global Crohn’s Disease Diagnostic and Therapeutic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Crohn’s Disease Diagnostic and Therapeutic Scope and Market Size
Crohn’s Disease Diagnostic and Therapeutic market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Crohn’s Disease Diagnostic and Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
AbbVie
Celgene Corporation
Genetech
Janssen Biotech
Johnson & Johnson
Pfizer
Prometheus Laboratories
Salix Pharmaceuticals
Takeda’s Pharmaceutical

Market segment by Type, the product can be split into
Blood Tests
Fecal Test
Colonoscopy
Flexible Sigmoidoscopy
Computerized Tomography
Magnetic Resonance Imaging
Capsule Endoscopy
Market segment by Application, split into
Clinic
Hospital

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Crohn’s Disease Diagnostic and Therapeutic Revenue
1.4 Market by Type
1.4.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Blood Tests
1.4.3 Fecal Test
1.4.4 Colonoscopy
1.4.5 Flexible Sigmoidoscopy
1.4.6 Computerized Tomography
1.4.7 Magnetic Resonance Imaging
1.4.8 Capsule Endoscopy
1.5 Market by Application
1.5.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Application: 2020 VS 2026
1.5.2 Clinic
1.5.3 Hospital
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Perspective (2015-2026)
2.2 Global Crohn’s Disease Diagnostic and Therapeutic Growth Trends by Regions
2.2.1 Crohn’s Disease Diagnostic and Therapeutic Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Crohn’s Disease Diagnostic and Therapeutic Historic Market Share by Regions (2015-2020)
2.2.3 Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Crohn’s Disease Diagnostic and Therapeutic Market Growth Strategy
2.3.6 Primary Interviews with Key Crohn’s Disease Diagnostic and Therapeutic Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Crohn’s Disease Diagnostic and Therapeutic Players by Market Size
3.1.1 Global Top Crohn’s Disease Diagnostic and Therapeutic Players by Revenue (2015-2020)
3.1.2 Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share by Players (2015-2020)
3.1.3 Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Crohn’s Disease Diagnostic and Therapeutic Market Concentration Ratio
3.2.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Crohn’s Disease Diagnostic and Therapeutic Revenue in 2019
3.3 Crohn’s Disease Diagnostic and Therapeutic Key Players Head office and Area Served
3.4 Key Players Crohn’s Disease Diagnostic and Therapeutic Product Solution and Service
3.5 Date of Enter into Crohn’s Disease Diagnostic and Therapeutic Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Crohn’s Disease Diagnostic and Therapeutic Historic Market Size by Type (2015-2020)
4.2 Global Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2015-2020)
5.2 Global Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Crohn’s Disease Diagnostic and Therapeutic Market Size (2015-2020)
6.2 Crohn’s Disease Diagnostic and Therapeutic Key Players in North America (2019-2020)
6.3 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2015-2020)
6.4 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2015-2020)

7 Europe
7.1 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size (2015-2020)
7.2 Crohn’s Disease Diagnostic and Therapeutic Key Players in Europe (2019-2020)
7.3 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2015-2020)
7.4 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2015-2020)

8 China
8.1 China Crohn’s Disease Diagnostic and Therapeutic Market Size (2015-2020)
8.2 Crohn’s Disease Diagnostic and Therapeutic Key Players in China (2019-2020)
8.3 China Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2015-2020)
8.4 China Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2015-2020)

9 Japan
9.1 Japan Crohn’s Disease Diagnostic and Therapeutic Market Size (2015-2020)
9.2 Crohn’s Disease Diagnostic and Therapeutic Key Players in Japan (2019-2020)
9.3 Japan Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2015-2020)
9.4 Japan Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Crohn’s Disease Diagnostic and Therapeutic Market Size (2015-2020)
10.2 Crohn’s Disease Diagnostic and Therapeutic Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2015-2020)
10.4 Southeast Asia Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2015-2020)

11 India
11.1 India Crohn’s Disease Diagnostic and Therapeutic Market Size (2015-2020)
11.2 Crohn’s Disease Diagnostic and Therapeutic Key Players in India (2019-2020)
11.3 India Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2015-2020)
11.4 India Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Crohn’s Disease Diagnostic and Therapeutic Market Size (2015-2020)
12.2 Crohn’s Disease Diagnostic and Therapeutic Key Players in Central & South America (2019-2020)
12.3 Central & South America Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2015-2020)
12.4 Central & South America Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 AbbVie
13.1.1 AbbVie Company Details
13.1.2 AbbVie Business Overview
13.1.3 AbbVie Crohn’s Disease Diagnostic and Therapeutic Introduction
13.1.4 AbbVie Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020))
13.1.5 AbbVie Recent Development
13.2 Celgene Corporation
13.2.1 Celgene Corporation Company Details
13.2.2 Celgene Corporation Business Overview
13.2.3 Celgene Corporation Crohn’s Disease Diagnostic and Therapeutic Introduction
13.2.4 Celgene Corporation Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020)
13.2.5 Celgene Corporation Recent Development
13.3 Genetech
13.3.1 Genetech Company Details
13.3.2 Genetech Business Overview
13.3.3 Genetech Crohn’s Disease Diagnostic and Therapeutic Introduction
13.3.4 Genetech Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020)
13.3.5 Genetech Recent Development
13.4 Janssen Biotech
13.4.1 Janssen Biotech Company Details
13.4.2 Janssen Biotech Business Overview
13.4.3 Janssen Biotech Crohn’s Disease Diagnostic and Therapeutic Introduction
13.4.4 Janssen Biotech Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020)
13.4.5 Janssen Biotech Recent Development
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Details
13.5.2 Johnson & Johnson Business Overview
13.5.3 Johnson & Johnson Crohn’s Disease Diagnostic and Therapeutic Introduction
13.5.4 Johnson & Johnson Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020)
13.5.5 Johnson & Johnson Recent Development
13.6 Pfizer
13.6.1 Pfizer Company Details
13.6.2 Pfizer Business Overview
13.6.3 Pfizer Crohn’s Disease Diagnostic and Therapeutic Introduction
13.6.4 Pfizer Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020)
13.6.5 Pfizer Recent Development
13.7 Prometheus Laboratories
13.7.1 Prometheus Laboratories Company Details
13.7.2 Prometheus Laboratories Business Overview
13.7.3 Prometheus Laboratories Crohn’s Disease Diagnostic and Therapeutic Introduction
13.7.4 Prometheus Laboratories Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020)
13.7.5 Prometheus Laboratories Recent Development
13.8 Salix Pharmaceuticals
13.8.1 Salix Pharmaceuticals Company Details
13.8.2 Salix Pharmaceuticals Business Overview
13.8.3 Salix Pharmaceuticals Crohn’s Disease Diagnostic and Therapeutic Introduction
13.8.4 Salix Pharmaceuticals Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020)
13.8.5 Salix Pharmaceuticals Recent Development
13.9 Takeda’s Pharmaceutical
13.9.1 Takeda’s Pharmaceutical Company Details
13.9.2 Takeda’s Pharmaceutical Business Overview
13.9.3 Takeda’s Pharmaceutical Crohn’s Disease Diagnostic and Therapeutic Introduction
13.9.4 Takeda’s Pharmaceutical Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020)
13.9.5 Takeda’s Pharmaceutical Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Crohn's Disease Diagnostic and Therapeutic Key Market Segments
Table 2. Key Players Covered: Ranking by Crohn's Disease Diagnostic and Therapeutic Revenue
Table 3. Ranking of Global Top Crohn's Disease Diagnostic and Therapeutic Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Crohn's Disease Diagnostic and Therapeutic Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Blood Tests
Table 6. Key Players of Fecal Test
Table 7. Key Players of Colonoscopy
Table 8. Key Players of Flexible Sigmoidoscopy
Table 9. Key Players of Computerized Tomography
Table 10. Key Players of Magnetic Resonance Imaging
Table 11. Key Players of Capsule Endoscopy
Table 12. Global Crohn's Disease Diagnostic and Therapeutic Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Crohn's Disease Diagnostic and Therapeutic Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Crohn's Disease Diagnostic and Therapeutic Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Crohn's Disease Diagnostic and Therapeutic Market Share by Regions (2015-2020)
Table 16. Global Crohn's Disease Diagnostic and Therapeutic Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Crohn's Disease Diagnostic and Therapeutic Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Crohn's Disease Diagnostic and Therapeutic Market Growth Strategy
Table 22. Main Points Interviewed from Key Crohn's Disease Diagnostic and Therapeutic Players
Table 23. Global Crohn's Disease Diagnostic and Therapeutic Revenue by Players (2015-2020) (Million US$)
Table 24. Global Crohn's Disease Diagnostic and Therapeutic Market Share by Players (2015-2020)
Table 25. Global Top Crohn's Disease Diagnostic and Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Crohn's Disease Diagnostic and Therapeutic as of 2019)
Table 26. Global Crohn's Disease Diagnostic and Therapeutic by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Crohn's Disease Diagnostic and Therapeutic Product Solution and Service
Table 29. Date of Enter into Crohn's Disease Diagnostic and Therapeutic Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Crohn's Disease Diagnostic and Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 32. Global Crohn's Disease Diagnostic and Therapeutic Market Size Share by Type (2015-2020)
Table 33. Global Crohn's Disease Diagnostic and Therapeutic Revenue Market Share by Type (2021-2026)
Table 34. Global Crohn's Disease Diagnostic and Therapeutic Market Size Share by Application (2015-2020)
Table 35. Global Crohn's Disease Diagnostic and Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 36. Global Crohn's Disease Diagnostic and Therapeutic Market Size Share by Application (2021-2026)
Table 37. North America Key Players Crohn's Disease Diagnostic and Therapeutic Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Crohn's Disease Diagnostic and Therapeutic Market Share (2019-2020)
Table 39. North America Crohn's Disease Diagnostic and Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 40. North America Crohn's Disease Diagnostic and Therapeutic Market Share by Type (2015-2020)
Table 41. North America Crohn's Disease Diagnostic and Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 42. North America Crohn's Disease Diagnostic and Therapeutic Market Share by Application (2015-2020)
Table 43. Europe Key Players Crohn's Disease Diagnostic and Therapeutic Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Crohn's Disease Diagnostic and Therapeutic Market Share (2019-2020)
Table 45. Europe Crohn's Disease Diagnostic and Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Crohn's Disease Diagnostic and Therapeutic Market Share by Type (2015-2020)
Table 47. Europe Crohn's Disease Diagnostic and Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Crohn's Disease Diagnostic and Therapeutic Market Share by Application (2015-2020)
Table 49. China Key Players Crohn's Disease Diagnostic and Therapeutic Revenue (2019-2020) (Million US$)
Table 50. China Key Players Crohn's Disease Diagnostic and Therapeutic Market Share (2019-2020)
Table 51. China Crohn's Disease Diagnostic and Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 52. China Crohn's Disease Diagnostic and Therapeutic Market Share by Type (2015-2020)
Table 53. China Crohn's Disease Diagnostic and Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 54. China Crohn's Disease Diagnostic and Therapeutic Market Share by Application (2015-2020)
Table 55. Japan Key Players Crohn's Disease Diagnostic and Therapeutic Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Crohn's Disease Diagnostic and Therapeutic Market Share (2019-2020)
Table 57. Japan Crohn's Disease Diagnostic and Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Crohn's Disease Diagnostic and Therapeutic Market Share by Type (2015-2020)
Table 59. Japan Crohn's Disease Diagnostic and Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Crohn's Disease Diagnostic and Therapeutic Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Crohn's Disease Diagnostic and Therapeutic Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Crohn's Disease Diagnostic and Therapeutic Market Share (2019-2020)
Table 63. Southeast Asia Crohn's Disease Diagnostic and Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Crohn's Disease Diagnostic and Therapeutic Market Share by Type (2015-2020)
Table 65. Southeast Asia Crohn's Disease Diagnostic and Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Crohn's Disease Diagnostic and Therapeutic Market Share by Application (2015-2020)
Table 67. India Key Players Crohn's Disease Diagnostic and Therapeutic Revenue (2019-2020) (Million US$)
Table 68. India Key Players Crohn's Disease Diagnostic and Therapeutic Market Share (2019-2020)
Table 69. India Crohn's Disease Diagnostic and Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 70. India Crohn's Disease Diagnostic and Therapeutic Market Share by Type (2015-2020)
Table 71. India Crohn's Disease Diagnostic and Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 72. India Crohn's Disease Diagnostic and Therapeutic Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Crohn's Disease Diagnostic and Therapeutic Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Crohn's Disease Diagnostic and Therapeutic Market Share (2019-2020)
Table 75. Central & South America Crohn's Disease Diagnostic and Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Crohn's Disease Diagnostic and Therapeutic Market Share by Type (2015-2020)
Table 77. Central & South America Crohn's Disease Diagnostic and Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Crohn's Disease Diagnostic and Therapeutic Market Share by Application (2015-2020)
Table 79. AbbVie Company Details
Table 80. AbbVie Business Overview
Table 81. AbbVie Product
Table 82. AbbVie Revenue in Crohn's Disease Diagnostic and Therapeutic Business (2015-2020) (Million US$)
Table 83. AbbVie Recent Development
Table 84. Celgene Corporation Company Details
Table 85. Celgene Corporation Business Overview
Table 86. Celgene Corporation Product
Table 87. Celgene Corporation Revenue in Crohn's Disease Diagnostic and Therapeutic Business (2015-2020) (Million US$)
Table 88. Celgene Corporation Recent Development
Table 89. Genetech Company Details
Table 90. Genetech Business Overview
Table 91. Genetech Product
Table 92. Genetech Revenue in Crohn's Disease Diagnostic and Therapeutic Business (2015-2020) (Million US$)
Table 93. Genetech Recent Development
Table 94. Janssen Biotech Company Details
Table 95. Janssen Biotech Business Overview
Table 96. Janssen Biotech Product
Table 97. Janssen Biotech Revenue in Crohn's Disease Diagnostic and Therapeutic Business (2015-2020) (Million US$)
Table 98. Janssen Biotech Recent Development
Table 99. Johnson & Johnson Company Details
Table 100. Johnson & Johnson Business Overview
Table 101. Johnson & Johnson Product
Table 102. Johnson & Johnson Revenue in Crohn's Disease Diagnostic and Therapeutic Business (2015-2020) (Million US$)
Table 103. Johnson & Johnson Recent Development
Table 104. Pfizer Company Details
Table 105. Pfizer Business Overview
Table 106. Pfizer Product
Table 107. Pfizer Revenue in Crohn's Disease Diagnostic and Therapeutic Business (2015-2020) (Million US$)
Table 108. Pfizer Recent Development
Table 109. Prometheus Laboratories Company Details
Table 110. Prometheus Laboratories Business Overview
Table 111. Prometheus Laboratories Product
Table 112. Prometheus Laboratories Revenue in Crohn's Disease Diagnostic and Therapeutic Business (2015-2020) (Million US$)
Table 113. Prometheus Laboratories Recent Development
Table 114. Salix Pharmaceuticals Business Overview
Table 115. Salix Pharmaceuticals Product
Table 116. Salix Pharmaceuticals Company Details
Table 117. Salix Pharmaceuticals Revenue in Crohn's Disease Diagnostic and Therapeutic Business (2015-2020) (Million US$)
Table 118. Salix Pharmaceuticals Recent Development
Table 119. Takeda's Pharmaceutical Company Details
Table 120. Takeda's Pharmaceutical Business Overview
Table 121. Takeda's Pharmaceutical Product
Table 122. Takeda's Pharmaceutical Revenue in Crohn's Disease Diagnostic and Therapeutic Business (2015-2020) (Million US$)
Table 123. Takeda's Pharmaceutical Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Crohn's Disease Diagnostic and Therapeutic Market Share by Type: 2020 VS 2026
Figure 2. Blood Tests Features
Figure 3. Fecal Test Features
Figure 4. Colonoscopy Features
Figure 5. Flexible Sigmoidoscopy Features
Figure 6. Computerized Tomography Features
Figure 7. Magnetic Resonance Imaging Features
Figure 8. Capsule Endoscopy Features
Figure 9. Global Crohn's Disease Diagnostic and Therapeutic Market Share by Application: 2020 VS 2026
Figure 10. Clinic Case Studies
Figure 11. Hospital Case Studies
Figure 12. Crohn's Disease Diagnostic and Therapeutic Report Years Considered
Figure 13. Global Crohn's Disease Diagnostic and Therapeutic Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Crohn's Disease Diagnostic and Therapeutic Market Share by Regions: 2020 VS 2026
Figure 15. Global Crohn's Disease Diagnostic and Therapeutic Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Crohn's Disease Diagnostic and Therapeutic Market Share by Players in 2019
Figure 18. Global Top Crohn's Disease Diagnostic and Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Crohn's Disease Diagnostic and Therapeutic as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Crohn's Disease Diagnostic and Therapeutic Revenue in 2019
Figure 20. North America Crohn's Disease Diagnostic and Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Crohn's Disease Diagnostic and Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Crohn's Disease Diagnostic and Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Crohn's Disease Diagnostic and Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Crohn's Disease Diagnostic and Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Crohn's Disease Diagnostic and Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Crohn's Disease Diagnostic and Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed